CVS Health (NYSE:CVS) Price Target Raised to $71.00 at Robert W. Baird

CVS Health (NYSE:CVS) had its target price upped by Robert W. Baird from $51.00 to $71.00 in a report issued on Tuesday morning,Benzinga reports. They currently have a neutral rating on the pharmacy operator’s stock.

A number of other research analysts have also recently issued reports on CVS. Truist Financial lifted their target price on shares of CVS Health from $76.00 to $82.00 and gave the company a “buy” rating in a research note on Friday, April 11th. Leerink Partners upgraded CVS Health from a “market perform” rating to an “outperform” rating and lifted their price objective for the company from $55.00 to $75.00 in a research report on Thursday, February 13th. Argus set a $77.00 target price on CVS Health in a research note on Tuesday, February 18th. StockNews.com upgraded shares of CVS Health from a “sell” rating to a “hold” rating in a research report on Thursday, February 13th. Finally, Cantor Fitzgerald upgraded shares of CVS Health from a “neutral” rating to an “overweight” rating in a research report on Wednesday, February 12th. Four research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $71.83.

CVS Health Trading Down 0.6 %

Shares of CVS stock opened at $68.80 on Tuesday. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81. The firm has a fifty day moving average of $65.67 and a 200-day moving average of $58.63. CVS Health has a 52-week low of $43.56 and a 52-week high of $71.66. The stock has a market cap of $86.74 billion, a price-to-earnings ratio of 18.80, a P/E/G ratio of 0.98 and a beta of 0.57.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, beating analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. On average, equities research analysts forecast that CVS Health will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd will be paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.87%. The ex-dividend date of this dividend is Tuesday, April 22nd. CVS Health’s payout ratio is 72.68%.

Insider Buying and Selling at CVS Health

In other CVS Health news, Director Michael F. Mahoney purchased 30,000 shares of the stock in a transaction on Tuesday, February 18th. The stock was bought at an average cost of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the acquisition, the director now directly owns 39,356 shares of the company’s stock, valued at $2,625,045.20. The trade was a 320.65 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP James David Clark sold 7,513 shares of CVS Health stock in a transaction that occurred on Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total transaction of $498,487.55. Following the completion of the transaction, the senior vice president now directly owns 8,394 shares in the company, valued at approximately $556,941.90. The trade was a 47.23 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.24% of the company’s stock.

Institutional Trading of CVS Health

Institutional investors have recently modified their holdings of the company. Morse Asset Management Inc bought a new stake in shares of CVS Health in the third quarter worth $409,000. Westside Investment Management Inc. lifted its position in CVS Health by 4.6% during the 3rd quarter. Westside Investment Management Inc. now owns 64,517 shares of the pharmacy operator’s stock worth $4,041,000 after buying an additional 2,856 shares in the last quarter. World Investment Advisors LLC boosted its stake in shares of CVS Health by 280.7% during the 3rd quarter. World Investment Advisors LLC now owns 27,543 shares of the pharmacy operator’s stock worth $1,732,000 after buying an additional 20,308 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new position in shares of CVS Health in the 3rd quarter valued at about $2,071,000. Finally, Tidal Investments LLC increased its position in shares of CVS Health by 52.2% in the third quarter. Tidal Investments LLC now owns 112,010 shares of the pharmacy operator’s stock valued at $7,043,000 after acquiring an additional 38,408 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.